Covalent inhibition of SUMO and ubiquitin-specific cysteine proteases by an in situ thiol-alkyne addition

Bioorg Med Chem. 2013 May 1;21(9):2511-7. doi: 10.1016/j.bmc.2013.02.039. Epub 2013 Mar 7.


Posttranslational modification of proteins with ubiquitin and ubiquitin-like modifiers such as SUMO can be reverted by specific proteases, also referred to as deubiquitinases and isopeptidases, most of which are cysteine-dependent. We have found that the replacement of the conserved C-terminal glycine with propargylamine converts SUMO and ubiquitin to highly efficient covalent inhibitors of their cognate cysteine proteases. Attack of the catalytic cysteine onto the terminal alkyne results in the formation of a vinyl sulfide linkage. Although this reaction is reminiscent of the inhibitory mechanism of the isosteric nitrile inhibitors it was unexpected due to the low electrophilicity of the alkyne group. We show that a precise location of the functional group in the active site of the protease is crucial for the reaction, which was not inhibited by the presence of a radical scavenger. Furthermore, a mutational study of key catalytic residues in the SUMO-protease Senp1, that is H533A and D550A of the catalytic triad and Q597A as part of the oxyanion hole, revealed that these residues are not required for the observed covalent adduct formation. We therefore propose that the reaction is an in situ thiol-alkyne addition. Due to the high chemical inertness of the alkyne moiety the respective protease inhibitors should be well-suited for cellular and therapeutic applications. In keeping with this idea, selective labeling with propargylated SUMO and Ub probes was observed in lysates of cell lines expressing the cognate proteases after transient transfection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alkynes / metabolism*
  • Animals
  • Cysteine Endopeptidases
  • Cysteine Proteinase Inhibitors / chemical synthesis
  • Cysteine Proteinase Inhibitors / chemistry
  • Cysteine Proteinase Inhibitors / pharmacology*
  • Dose-Response Relationship, Drug
  • Endopeptidases / metabolism*
  • Mice
  • Molecular Structure
  • Structure-Activity Relationship
  • Sulfhydryl Compounds / metabolism*
  • Tumor Cells, Cultured


  • Alkynes
  • Cysteine Proteinase Inhibitors
  • Sulfhydryl Compounds
  • Endopeptidases
  • Cysteine Endopeptidases
  • Senp1 protein, mouse